Showing results (491-500 of 1,794) with videos related to

Sort By:
Pageof 180
Mabs|September 21, 2020
An accelerated surface-mediated stress assay of antibody instability for developability studiesMarie R G Kopp, Adriana-Michelle Wolf Pérez, Marta Virginia Zucca, et al.
Mabs|September 7, 2020
Engineered Fc-glycosylation switch to eliminate antibody effector functionQun Zhou, Julie Jaworski, Yanfeng Zhou, et al.
Mabs|January 7, 2020
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptorXiaoshan Min, Junming Yie, Jinghong Wang, et al.
Mabs|March 20, 2020
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumorsEric Hatterer, Xavier Chauchet, Françoise Richard, et al.
Mabs|March 14, 2020
Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approachJoanna Hajduk, Cyrill Brunner, Sebastian Malik, et al.
Mabs|January 26, 2020
In situ antibody phage display yields optimal inhibitors of integrin α11/β1Eugenio Gallo, Abdellali Kelil, Peter E Bayliss, et al.
Mabs|November 27, 2019
Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levelsJay Jones, Laura Pack, Joshua H Hunter, et al.
Mabs|November 27, 2019
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.
Mabs|December 5, 2018
CH2 domain orientation of human immunoglobulin G in solution: Structural comparison of glycosylated and aglycosylated Fc regions using small-angle X-ray scatteringSeiki Yageta, Hiroshi Imamura, Risa Shibuya, et al.
Mabs|October 26, 2020
Beyond affinity: selection of antibody variants with optimal biophysical properties and reduced immunogenicity from mammalian display librariesMichael R Dyson, Edward Masters, Deividas Pazeraitis, et al.
Pageof 180